Commons2nd readingView on Parliament.uk

Gamma-Butyrolactone (Prohibition) Bill

To provide for the classification of gamma-butyrolactone as a Class C drug under the Misuse of Drugs Act 1971; and for connected purposes

Originating House

House of Commons

Last Updated

7 November 2008

In Plain English

AI-generated

If passed, the Gamma-Butyrolactone (Prohibition) Bill would classify gamma-butyrolactone (GBL) as a Class C drug under the Misuse of Drugs Act 1971. It would make it illegal to possess, supply, produce or import GBL unless licensed or exempted, with penalties under drug-offence laws. The aim is to curb illegal use and related harm by bringing GBL into the drug-control framework.

Key Points

GBL would be listed as a Class C controlled drug under the Misuse of Drugs Act 1971.
Offences would cover possession, supply, production and import of GBL without proper authorisation.
The bill enables licensing, regulation and enforcement within the existing drug-control system.

Who is affected?

Individuals who possess, use or sell GBLBusinesses and workers involved in manufacturing, importing, distributing or selling GBLLaw enforcement, prosecutors and the courtsHealth services and treatment providers dealing with GBL-related harm

Generated 21 February 2026

Parliamentary Votes (0)

No recorded votes for this bill yet.